Irisin in response to exercise in humans with and without metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages E453-E457

  Huh, Joo Young ^a,d   Siopi, Aikaterina ^b   Mougios, Vassilis ^b   Park, Kyung Hee ^a,c   Mantzoros, Christos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Hallym University Sacred Heart Hospital   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; IRISIN; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS MODERATE INTENSITY EXERCISE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; EXERCISE; HIGH INTENSITY INTERVAL EXERCISE; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; TREATMENT RESPONSE; BLOOD; ENDURANCE; PHYSIOLOGY; RUNNING; WALKING;

ADULT; CROSS-OVER STUDIES; EXERCISE; FIBRONECTINS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICAL ENDURANCE; RESISTANCE TRAINING; RUNNING; WALKING;

EID: 84924971948     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2416     Document Type: Article

References (22)

1. Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33:e147-e167.
2. Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metabol. 2013;17:162-184.
3. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Endocrinology. 2012;8:457-465.
4. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
5. Crujeiras AB, Zulet MA, Lopez-Legarrea P, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014;63:520-531.
6. Moon HS, Dincer F, Mantzoros CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism. 2013;62:1131-1136.
7. Moon HS, Mantzoros CS. Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines. Metabolism. 2014;63:188-193.
8. Park KH, Zaichenko L, Peter P, Davis CR, Crowell JA, Mantzoros CS. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism. 2014;63:233-241.
9. Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS. Irisin in patients with nonalcoholic fatty liver disease. Metabolism. 2014;63:207-217.
10. Roberts MD, Bayless DS, Company JM, et al. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism. 2013;62:1052-1056.
11. Swick AG, Orena S, O'Connor A. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism. 2013;62:1070-1073.
12. Tanisawa K, Taniguchi H, Sun X, et al. Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels. Metabolism. 2014;63:574-583.
13. Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899-4907.
14. Norheim F, Langleite TM, Hjorth M, et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014;281:739-749.
15. Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Horm Metab Res. 2014;46:150-154.
16. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725-1738.
17. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
18. Huh JY, Dincer F, Mesfum E, Mantzoros CS. 2014 Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes (Lond). 2014;38:1538-1544.
19. Zhang Y, Li R, Meng Y, et al. Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling. Diabetes. 2014;63:514-525.
20. Vaughan RA, Gannon NP, Barberena MA, et al. 2014 Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 2014;16:711-718.
21. Dohoney P, Chromiak JA, Lemire D, Abadie BR, Kovacs C. Prediction of one repetition maximum (1-RM) strength from a 4-6 RM and a 7-8 RM submaximal strength test in healthy young adult males. J Exerc Physiol Online. 2002;5:54-59.
22. Crujeiras AB, Pardo M, Casanueva FF. Irisin: 'Fat' or artefact. Clin Endocrinol (Oxf). 10.1111/cen. 12627.